FDA Approves Datroway for Unresectable or Metastatic, HR-positive, HER2-negative Breast Cancer

The FDA has approved datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo), a Trop-2−directed antibody and ...

JANUARY 22, 2025